Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.


Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Pars planitis

Other Names for this Disease
  • Familial pars planitis (subtype)
  • Intermediate uveitis
  • Peripheral retinal inflammation
  • Vitritis
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.


Newline Maker

How might pars planitis be treated?

The first approach to treating pars planitis is to inject steroids near the eye to control inflammation.  If several injections are given without success, non-steroidal anti-inflammatory drugs (NSAIDs, including aspirin) or steroid medications (such as prednisone) may be taken by mouth.  If these are also unsuccessful, other medications may be given to reduce the body's immune responses (medications called immunosuppressants, such as methotrexate). 

If medications are not effective, surgery may be considered.  Cryosurgery has been performed in affected individuals to remove eye tissue that has inflammation.  Although this surgery has been shown to be effective in restoring clarity of vision, there are concerns that it may cause damage to other parts of the eye.  Another surgery, known as vitrectomy, can be done to remove cloudy fluid (vitreous humor) from the eye.[1]
Last updated: 4/8/2012

  1. Prieto JF, Dios E, Gutierrez JM, Mayo A, Calonge M, Herreras JM. Pars planitis: epidemiology, treatment, and association with multiple sclerosis. Ocular immunology and inflammation. 2001; 9:93-102. Accessed 4/3/2012.

Clinical Trials & Research for this Disease

  • lists trials that are studying or have studied Pars planitis. Click on the link to go to to read descriptions of these studies.